SCHEMBL22011402

SCHEMBL22011402

c1ccc2c(c1)-c1cccc3c(-n4c5ccccc5c5c6ccc7oc8ccccc8c7c6c6c7ccccc7oc6c54)ccc-2c13

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 2/20 0.33
CRHR2 Q13324 2/20 0.33
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33
MEN1 O00255 6/20 0.32
KMT2A Q03164 6/20 0.32
MAPT P10636 3/20 0.32
HTT P42858 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TLR9 Q9NR96 1/20 0.32
ALOX5 P09917 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
CASP1 P29466 1/20 0.32
HBB P68871 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RAB9A P51151 2/20 0.31
MAPK1 P28482 2/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22011530 0.92 ALOX5 (0.32) CRHBPCRHR2KEAP1NFE2L2ALOX5
SCHEMBL19986092 0.89 CRHBP (0.36) CRHBPCRHR2KEAP1NFE2L2L3MBTL1
SCHEMBL17341544 0.89 CRHBP (0.37) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL17405533 0.89 KEAP1 (0.37) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL17405650 0.88 CRHBP (0.36) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL17405734 0.85 ALOX5 (0.35) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL17341547 0.84 CRHBP (0.36) CRHBPCRHR2KEAP1NFE2L2L3MBTL1
SCHEMBL17341548 0.84 ALOX5 (0.36) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL17341620 0.84 ALOX5 (0.36) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL16275615 0.84 ALOX5 (0.35) CRHBPCRHR2KEAP1NFE2L2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
EP-3880682-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-06-14 EP disclosed
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-01-06 US disclosed
WO-2020099307-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES ZYX, RER1, AOC2 CRHBP 4475/4885CRHR2 1820/4885KEAP1 928/4885
US-12035625-B2 Materials for organic electroluminescent devices ZYX, RER1, AOC2 CRHBP 4475/4885CRHR2 1820/4885KEAP1 928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.